Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Clinical Study Sites-TLD 1433 in the United States.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(443)
•••
Post by Infinityon Apr 04, 2022 3:14pm
220 Views
Post# 34574155

Clinical Study Sites-TLD 1433 in the United States.

Clinical Study Sites-TLD 1433 in the United States.I was wondering if there was any updates on the Clinical Study sites on their Web Page.  Some of the Clinical Study Sites do not even have TLD1433 or PDT as an option in the Clinical Trials

  1.  University of Chicago Link:  Clinical study sites

https://www.uchicagomedicine.org/find-a-clinical-trial?page=1&conditionId=d4bf1868b7104275acd1089ebce4959a


  1.  Urology San Antonio Study Site link

https://www.urologysanantonio.com/clinical-trials-current-studies



  1. University of Wisconsin Madison:  Mentions a clinical study using PDT 


https://clinicaltrials.uwhealth.org/studies?commit=Search&page=2&search%5Bcategory%5D=3&search%5Bgender%5D=&search%5Bhealthy_volunteers%5D=&search%5Bq%5D=bladder&utf8=%E2%9C%93


  1. Carolina Urologic center: Mentions their clinical study with Theralase and end date May 2022

https://carolinaurologicresearchcenter.com/current-trials/current-trials-bladder-cancer/



  1. Midlantic Urology:  Link has Theralase Tech as part of their Clinical Trials


https://midlanticurology.com/clinical-research


  1.  Urology associates Nashville TN


https://www.urologynashville.com/centers-of-excellence/research/


  1.  Urology Virginia

https://www.uro.com/about-us/clinical-trials-research/


 

 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities